Biogen and UCB’s lupus drug reached sustained remission in more patients. Why the real test is still two years away
New Phase 3 analyses strengthen dapirolizumab’s lupus profile, but Biogen and UCB still need PHOENYCS FLY to confirm efficacy.
Pharma & Biotech